Trials / Unknown
UnknownNCT06062355
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics and Radiation Dosimetry of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the the safety, pharmacokinetics, radiation dosimetry of HRS-9815 for PET/CT imaging in adult patients with prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-9815 injection | HRS-9815 injection |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2023-10-02
- Last updated
- 2023-10-02
Source: ClinicalTrials.gov record NCT06062355. Inclusion in this directory is not an endorsement.